Cms-10434 #26 Cqm2017-apc

Centers for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
CQM 2017 - Use of Multiple Concurrent
Antipsychotics in Children and Adolescents
(APC) Core Measure PRA Document
Version 1.0
08/24/2017

Document Number: 281-QSSI-MACPro-PRA-CQM2017-APC-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC)
Screenshots ............................................................................................................. 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10

Measurement Specifications – Path 1 ............................................................. 1
Measurement Specifications – Path 2 ............................................................. 1
Data Source .................................................................................................... 1
Performance Measure - Path 1 ....................................................................... 2
Performance Measure - Path 2 ....................................................................... 2
Deviations from Measure Specifications – Screenshot 1 ................................ 3
Deviations from Measure Specifications – Screenshot 2 ................................ 3
Deviations from Measure Specifications – Screenshot 3 ................................ 4
Optional Measure Stratification – Screenshot 1 .............................................. 4
Optional Measure Stratification – Screenshot 2 .............................................. 5

Appendix A: Acronyms ................................................................................................. 6

List of Figures
Figure 1: Measurement Specifications – Path 1 .............................................................. 1
Figure 2: Measurement Specifications – Path 2 .............................................................. 1
Figure 3 : Data Source .................................................................................................... 1
Figure 4: Performance Measure - Path 1 ........................................................................ 2
Figure 5: Performance Measure - Path 2 ........................................................................ 2
Figure 6: Deviations from Measure Specifications – Screenshot 1 ................................. 3
Figure 7 : Deviations from Measure Specifications – Screenshot 2 ................................ 3
Figure 8 : Deviations from Measure Specifications – Screenshot 3 ................................ 4
Figure 9 : Optional Measure Stratification – Screenshot 1 .............................................. 4
Figure 10: Optional Measure Stratification – Screenshot 2 ............................................. 5

List of Tables
No table of figures entries found.

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
i
08/24/2017

CMS XLC

Measurement Specifications – Path 1

1. Use of Multiple Concurrent Antipsychotics in Children
and Adolescents (APC) Screenshots
1.1

Measurement Specifications – Path 1

Figure 1: Measurement Specifications – Path 1

1.2

Measurement Specifications – Path 2

Figure 2: Measurement Specifications – Path 2

1.3

Data Source

Figure 3 : Data Source

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
1
08/24/2017

CMS XLC

1.4

Performance Measure - Path 1

Performance Measure - Path 1

Figure 4: Performance Measure - Path 1

1.5

Performance Measure - Path 2

Figure 5: Performance Measure - Path 2

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
2
08/24/2017

CMS XLC

1.6

Deviations from Measure Specifications – Screenshot 1

Deviations from Measure Specifications – Screenshot 1

Figure 6: Deviations from Measure Specifications – Screenshot 1

1.7

Deviations from Measure Specifications – Screenshot 2

Figure 7 : Deviations from Measure Specifications – Screenshot 2

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
3
08/24/2017

CMS XLC

1.8

Deviations from Measure Specifications – Screenshot 3

Deviations from Measure Specifications – Screenshot 3

Figure 8 : Deviations from Measure Specifications – Screenshot 3

1.9

Optional Measure Stratification – Screenshot 1

Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 9 : Optional Measure Stratification – Screenshot 1

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
4
08/24/2017

CMS XLC

Optional Measure Stratification – Screenshot 2

1.10 Optional Measure Stratification – Screenshot 2

Figure 10: Optional Measure Stratification – Screenshot 2

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
5
08/24/2017

CMS XLC

Optional Measure Stratification – Screenshot 2

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Definition

CQM

Child Quality Measures

PRA

Paperwork Reduction Act of 1995

CQM 2017 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Core Measure PRA Document Version
1.0
6
08/24/2017